Literature DB >> 15127010

Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV.

Lillian Sung1, James R Anderson, Carola Arndt, R Beverly Raney, William H Meyer, Alberto S Pappo.   

Abstract

We identified all children enrolled in the Intergroup Rhabdomyosarcoma Study Group-IV with neurofibromatosis type I (NF1) and rhabdomyosarcoma. Among 1025 eligible patients, 5 (0.5 %) had NF1. Three children had relapses, two of whom died of progressive disease. Patients with NF1 and rhabdomyosarcoma should be treated with intensive contemporary therapy protocols.

Entities:  

Mesh：

Year:  2004        PMID： 15127010     DOI： 10.1016/j.jpeds.2004.02.026

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  28 in total

Review 1.  Advances in pediatric rhabdomyosarcoma characterization and disease model development.

Authors:  D O'Brien; A G Jacob; S J Qualman; D S Chandler
Journal:  Histol Histopathol       Date:  2012-01       Impact factor: 2.303

Review 2.  A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

Authors:  Nancy Ratner; Shyra J Miller
Journal:  Nat Rev Cancer       Date:  2015-04-16       Impact factor: 60.716

3.  fdg-pet in two cases of neurofibromatosis type 1 and atypical malignancies.

Authors:  P de Blank; K Cole; L Kersun; A Green; J J Wilkes; J Belasco; R Bagatell; L C Bailey; M J Fisher
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

Review 4.  Sarcomas Associated With Genetic Cancer Predisposition Syndromes: A Review.

Authors:  Mohamad Farid; Joanne Ngeow
Journal:  Oncologist       Date:  2016-07-08

Review 5.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

6.  Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.

Authors:  Emre Cecen; Dilek Ince; Kamer Mutafoglu Uysal; Erdener Ozer; Riza Cetingoz; Ali Aykan Ozguven; Handan Cakmakci; Faik Sarialioglu; Nur Olgun
Journal:  Childs Nerv Syst       Date:  2011-03-26       Impact factor: 1.475

7.  DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome.

Authors:  Leslie Doros; Jiandong Yang; Louis Dehner; Christopher T Rossi; Kerry Skiver; Jason A Jarzembowski; Yoav Messinger; Kris Ann Schultz; Gretchen Williams; Nicolas André; D Ashley Hill
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

8.  Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.

Authors:  Simona Ognjanovic; Amy M Linabery; Bridget Charbonneau; Julie A Ross
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

Review 9.  Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis.

Authors:  Jesse Lee Kresak; Meggen Walsh
Journal:  J Pediatr Genet       Date:  2016-03-09

10.  A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.

Authors:  Adepitan A Owosho; Shih-Chiang Huang; Sonja Chen; Shruti Kashikar; Cherry L Estilo; Suzanne L Wolden; Leonard H Wexler; Joseph M Huryn; Cristina R Antonescu
Journal:  Oral Oncol       Date:  2016-09-06       Impact factor: 5.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.